
INDEPENDENT RESEARCH MEDIA HOUSE FOR THE ASX. DEPTH OVER HYPE.
The Calmer Co. (ASX CCO), Research and Coverage
The Calmer Co. International Limited (ASX: CCO) sells kava drinks, powders and extracts. It is based in Brisbane. Its brands are Fiji Kava, Taki Mai and Danodan. Fiji Kava powders are ranged in Coles and Woolworths, and the company sells on Amazon in the United States and wholesale to other businesses. Revenue was A$8.12 million in the year to 30 June 2026 and the loss was A$3.81 million (annual report, lodged 31 August 2026). Cash was A$953,000 at 30 September 2026 (Appendix 4C, lodged 30 October 2026). Samso had published 4 pieces on the company at 19 November 2026.
ASX code: CCO. Full legal name: The Calmer Co. International Limited. Managing Director and chief executive: Zane Yoshida, the founder. James Tonkin is the non-executive chairman. The other directors are Griffon Emose and Karl Schlobohm, both non-executive (annual report, lodged 31 August 2026). The Calmer Co. held A$953,000 in cash at 30 September 2026. The quarterly cash flow report (Appendix 4C) for that quarter lists A$2.27 million of convertible notes, all drawn. In the same report the company said it was progressing the placement of the remaining shortfall from its entitlement offer (lodged 30 October 2026). The annual report also shows a United States small business loan of A$0.20 million and other borrowings of A$0.19 million at 30 June 2026 (note 27, lodged 31 August 2026).
What The Calmer Co. sells
The Calmer Co. sells kava products under three brands and as a bulk ingredient. Kava is a Pacific plant. Its root is traditionally prepared with water as a drink. The company describes its products as promoting relaxation and sleep support (ASX announcement, 8 October 2026). Supply comes from growers in Fiji, Papua New Guinea and Vanuatu, and the company has a manufacturing facility at Navua in Fiji (annual report, lodged 31 August 2026).
- Fiji Kava. The main brand. It covers instant and traditional drinking powders, capsules and FZZR, a flavoured effervescent product. Fiji Kava is stocked by Coles and Woolworths in Australia and sold on Amazon in the United States (annual report, lodged 31 August 2026).
- Taki Mai. Kava shots, flavoured products, tinctures and drinking kava (annual report, lodged 31 August 2026).
- Danodan. The company's hemp brand for the United States, with its heritage in Oregon. It sells hemp and CBD oils and salves (annual report, lodged 31 August 2026).
- Wholesale and ingredients. Kava powder and kava extracts sold to other businesses. An extract is a concentrate of the active compounds in the root. The extracts are made with water or with pressurised carbon dioxide, which the company calls CO2 extraction (annual report, lodged 31 August 2026). It says CO2 extraction is done by specialist partners in Australia and India (ASX announcement, 17 August 2026).
Powder brought in A$6.38 million of the A$8.12 million of customer revenue in the year to 30 June 2026. Extracts brought in A$1.25 million and ready-to-drink products A$0.33 million. By market, Australia contributed A$4.07 million, against A$5.54 million the year before. The United States contributed A$3.82 million, against A$2.21 million, and Fiji A$0.22 million (annual report, note 10, lodged 31 August 2026).
Coles, Woolworths and the Fiji Kava FZZR launch
The Calmer Co. sells Fiji Kava powders through both major Australian supermarket chains. In October 2026 the 150 gram pack was ranged in 837 Coles stores and the 50 gram pack in 788. Ranged means a retailer has agreed to stock a product in those stores. The 50 gram pack was in 1,006 Woolworths stores, where it launched nationally in June 2025. Citing Coles scan data, the company says Fiji Kava ranks first by value of sales in the supermarket's national Stress category (ASX announcement, 8 October 2026).
Coles placed its first order for Fiji Kava FZZR, in a Piña Colada flavour, for 583 stores. The rollout was expected to start in the week of 12 October 2026. FZZR is a listed complementary medicine on the Australian Register of Therapeutic Goods, which the Therapeutic Goods Administration regulates (ASX announcement, 8 October 2026). The company says this pathway allows standardised kava extracts and flavours that Australian food rules for kava do not (ASX announcement, 24 June 2026).
Retail was the largest channel in the September 2026 quarter at A$975,037, about 40 per cent of revenue. Amazon USA sales were A$461,003. In the United States the company sells online and wholesale. Distribution through physical stores has not started there, and a broker, VDriven, has been appointed to support it (quarterly report, lodged 30 October 2026, and ASX announcement, 24 June 2026).
The company reported in December 2025 that the United States Food and Drug Administration had said traditionally prepared kava drinks, made only from kava root and water, are food under federal law. Its shots, tinctures and capsules are sold there as dietary supplements (ASX announcement, 23 December 2025).
The Calmer Co. wholesale ingredients and the 2026 agreements
Wholesale revenue was A$831,569 in the September 2026 quarter, about 34 per cent of the total, and about 91 per cent of it came from the United States. It was A$305,740 in the June 2026 quarter. The company attributes the rise to the timing of customer orders (quarterly report, lodged 30 October 2026). It announced three agreements in mid-2026 that relate to this channel.
- Manufacturing. A binding heads of agreement with the Kaiming Agro Processing group, which is building a plant at Navua with CO2 extraction. Commissioning was expected in December 2026. The first phase would move agreed equipment and production to that plant, subject to definitive agreements still to be negotiated (ASX announcement, 30 July 2026).
- Supply. An unnamed Pacific supplier will hold at least 10 tonnes of kava a month from Papua New Guinea and Vanuatu for the company. The company puts the indicative value at about A$8.65 million a year and says it has no obligation to buy that amount (ASX announcement, 6 August 2026).
- Distribution. An unnamed multinational ingredients company has exclusive rights to distribute the kava extracts in Australia, New Zealand, the United States, Canada and ASEAN markets. To keep those rights its purchases must reach about A$25 million over the first three years, including about A$5.5 million in the first year. Those amounts are a condition of exclusivity (ASX announcement, 17 August 2026). The September quarter report, lodged 30 October 2026, does not yet report purchases under the agreement.
The Calmer Co. revenue, cash and debt
Revenue was A$8.12 million in the year to 30 June 2026, against A$8.03 million the year before. Gross profit was A$2.87 million. The gross margin fell to 35.3 per cent from 42.5 per cent, which the company attributes to a shift in the mix of sales channels. The loss was A$3.81 million, against A$3.99 million. Cash used in operations fell to A$2.94 million from A$4.37 million (annual report, lodged 31 August 2026).
For the September 2026 quarter the company reported revenue of A$2.44 million, which it calls a record. It received A$1.79 million from customers and used A$755,000 in operations. The Appendix 4C divides the cash by that outflow and gives 1.3 quarters of funding. The company expects the outflow to reduce as inventory is sold. It has an inventory finance facility of FJ$250,000 from Fiji Investment Corporation, available from the December 2026 quarter (quarterly report and Appendix 4C, lodged 30 October 2026).
The annual accounts were prepared on a going concern basis. The directors describe a material uncertainty over the group continuing as a going concern. Current liabilities exceeded current assets by A$1.15 million at 30 June 2026, and total liabilities exceeded total assets by A$0.45 million. The same note says the directors believe the group will be able to carry out its funding and operating plans (annual report, lodged 31 August 2026).
After the year end the company ran an entitlement offer of one new share for each share held, at A$0.001 a share. It sought up to A$3.5 million and raised A$1,817,935 before costs. That sum includes A$365,000 applied by holders of its convertible notes (ASX announcement, 2 September 2026).
The company has two sets of convertible notes.
- Secured notes. A$1.4 million was issued in late 2025, secured over all the company's assets. The balance was A$1,035,000 after the entitlement offer (ASX announcement, 2 September 2026). The annual report gives their maturity date as 31 December 2026 (note 9, lodged 31 August 2026). Their terms set interest at 18 per cent a year from 1 August 2026. Under those terms they convert at A$0.003 a share only if the volume-weighted average share price is at least A$0.004 over the 15 trading days before maturity. Otherwise the terms require repayment in cash (ASX announcement, 18 December 2025).
- Unsecured note. FJ$2 million issued to BSP Life (Fiji) Limited around 28 February 2022 (prospectus, lodged 27 July 2026), with a five-year term and interest of 5 per cent a year (Appendix 4C, lodged 30 October 2026). In July 2026 the company said it was seeking a later maturity date and believed there was a reasonable likelihood it would be agreed (prospectus, lodged 27 July 2026).
Every Samso piece on The Calmer Co.
4 published pieces as at 19 November 2026, grouped by Samso product. Newest first in each group. Dates are Perth dates.
Samso News
- 17 Oct 2025, The Calmer Co. International Limited Q1 FY26 - Record $2.4m Quarterly Sales (+26%) - The Kava Revolution.
- 22 Aug 2025, The Calmer Co. Expands Strategic Footprint – Lease Secured in Fiji and Coles Sales Surge - Building a Kava Lifestyle Story.
- 14 Jul 2025, The Calmer Co. International Limited (ASX: CCO): Surging Revenue, Flavoured Kava Shots, and a Bold US Market Push.
- 28 May 2025, The Calmer Co. (ASX: CCO): Doubling Down on Calm – Amazon Sales Surge 104% - The Kava Calming Story.
Questions people ask about The Calmer Co. (ASX CCO)
What does The Calmer Co. do? It sells kava drinks, powders and extracts under the Fiji Kava and Taki Mai brands, and hemp products under the Danodan brand. Its customers are supermarkets, online shoppers and other businesses in Australia, the United States and Fiji.
Was The Calmer Co. called Fiji Kava (ASX FIJ)? Yes. The ASX code change list records the change of name from Fiji Kava Limited (ASX: FIJ) to The Calmer Co International Limited (ASX: CCO) as of 21 April 2023.
What is The Calmer Co. share price? The ASX website shows the CCO share price. This page lists Samso's coverage and has no live price.
What is the latest announcement from The Calmer Co.? As at 19 November 2026 the newest item on the ASX list was the results of the annual general meeting, lodged on 12 November 2026.
Does The Calmer Co. make a profit or pay a dividend? The company reported a loss of A$3.81 million for the year to 30 June 2026 on revenue of A$8.12 million. No dividend was paid or declared for that year (annual report, lodged 31 August 2026).
Is The Calmer Co. worth looking at? This page gives no buy, sell or hold call, price target or valuation. Fiji Kava powders were ranged in up to 837 Coles stores and in 1,006 Woolworths stores in October 2026. The company reported record quarterly revenue of A$2.44 million for the September 2026 quarter. Cash was A$953,000 at 30 September 2026, and the annual accounts describe a material uncertainty over going concern. Secured convertible notes had a balance of A$1,035,000 at 2 September 2026. The annual report gives their maturity date as 31 December 2026. Samso had published no research workup on The Calmer Co. at 19 November 2026. The Samso News piece of 17 October 2025 is the most recent.
Disclosure
Samso's News piece of 17 October 2025 commented on the company's revenue "for me as an investor". Samso holds no shares in The Calmer Co. International at 17 November 2026.
This page is general information only.
Depth over hype.
Samso company research pages are independent research commentary for general information only. Nothing on this page is financial product advice, and it does not take into account any reader's objectives, financial situation or needs. Figures are drawn from public sources believed reliable at the stated dates but are not guaranteed, and market-sensitive numbers change daily. Samso or associated parties may hold positions in, or have commercial arrangements with, companies mentioned. Seek professional advice before making investment decisions. © Samso 2026, samso.com.au
Page last reviewed 19 November 2026.